Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Isolation and Profiling of Circulating Tumor-Associated Exosomes Using Extracellular Vesicular Lipid-Protein Binding Affinity Based Microfluidic Device.

Kang YT, Purcell E, Palacios-Rolston C, Lo TW, Ramnath N, Jolly S, Nagrath S.

Small. 2019 Oct 7:e1903600. doi: 10.1002/smll.201903600. [Epub ahead of print]

PMID:
31588683
2.

Multiplex isolation and profiling of extracellular vesicles using a microfluidic DICE device.

Kang YT, Purcell E, Hadlock T, Lo TW, Mutukuri A, Jolly S, Nagrath S.

Analyst. 2019 Oct 7;144(19):5785-5793. doi: 10.1039/c9an01235d. Epub 2019 Aug 29.

PMID:
31463505
3.

Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells.

Cheng YH, Chen YC, Lin E, Brien R, Jung S, Chen YT, Lee W, Hao Z, Sahoo S, Min Kang H, Cong J, Burness M, Nagrath S, S Wicha M, Yoon E.

Nat Commun. 2019 May 15;10(1):2163. doi: 10.1038/s41467-019-10122-2.

4.

A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells.

Kim TH, Wang Y, Oliver CR, Thamm DH, Cooling L, Paoletti C, Smith KJ, Nagrath S, Hayes DF.

Nat Commun. 2019 Apr 1;10(1):1478. doi: 10.1038/s41467-019-09439-9.

5.

Detection of CTC Clusters and a Dedifferentiated RNA-Expression Survival Signature in Prostate Cancer.

Kozminsky M, Fouladdel S, Chung JS, Wang Y, Smith DC, Alva A, Azizi E, Morgan T, Nagrath S.

Adv Sci (Weinh). 2018 Nov 15;6(2):1801254. doi: 10.1002/advs.201801254. eCollection 2019 Jan 23.

6.

PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer.

Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S.

Sci Rep. 2019 Jan 24;9(1):566. doi: 10.1038/s41598-018-36096-7.

7.

Introduction: Liquid Biopsies.

Nagrath S, Jack RM.

Cancer J. 2018 Mar/Apr;24(2):59-60. doi: 10.1097/PPO.0000000000000313. No abstract available.

PMID:
29601330
8.

Circulating Tumor Cells: Diagnostic and Therapeutic Applications.

Lin E, Cao T, Nagrath S, King MR.

Annu Rev Biomed Eng. 2018 Jun 4;20:329-352. doi: 10.1146/annurev-bioeng-062117-120947. Epub 2018 Mar 14. Review.

PMID:
29539267
9.

Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.

Praharaj PP, Bhutia SK, Nagrath S, Bitting RL, Deep G.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):117-127. doi: 10.1016/j.bbcan.2017.12.005. Epub 2018 Jan 31. Review.

10.

Label-Free, High-Throughput Purification of Satellite Cells Using Microfluidic Inertial Separation.

Syverud BC, Lin E, Nagrath S, Larkin LM.

Tissue Eng Part C Methods. 2018 Jan;24(1):32-41. doi: 10.1089/ten.TEC.2017.0316. Epub 2017 Nov 6.

11.

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.

Lin E, Rivera-Báez L, Fouladdel S, Yoon HJ, Guthrie S, Wieger J, Deol Y, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S.

Cell Syst. 2017 Sep 27;5(3):295-304.e4. doi: 10.1016/j.cels.2017.08.012. Epub 2017 Sep 20.

12.

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Murlidhar V, Reddy RM, Fouladdel S, Zhao L, Ishikawa MK, Grabauskiene S, Zhang Z, Lin J, Chang AC, Carrott P, Lynch WR, Orringer MB, Kumar-Sinha C, Palanisamy N, Beer DG, Wicha MS, Ramnath N, Azizi E, Nagrath S.

Cancer Res. 2017 Sep 15;77(18):5194-5206. doi: 10.1158/0008-5472.CAN-16-2072. Epub 2017 Jul 17.

13.

Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2017 Jun 6;8(23):38075. doi: 10.18632/oncotarget.18369. No abstract available.

14.

Microfluidic continuum sorting of sub-populations of tumor cells via surface antibody expression levels.

Jack R, Hussain K, Rodrigues D, Zeinali M, Azizi E, Wicha M, Simeone DM, Nagrath S.

Lab Chip. 2017 Mar 29;17(7):1349-1358. doi: 10.1039/c6lc01496h.

PMID:
28294230
15.

The incorporation of microfluidics into circulating tumor cell isolation for clinical applications.

Kozminsky M, Wang Y, Nagrath S.

Curr Opin Chem Eng. 2016 Feb;11:59-66. Epub 2016 Feb 10.

16.

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.

Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, Daignault-Newton S, El-Sawy L, Wilson SJ, Chou A, Ignatoski KW, Keller E, Thomas D, Nagrath S, Morgan T, Day ML.

Cancer Res. 2017 Jan 1;77(1):74-85. doi: 10.1158/0008-5472.CAN-16-1656. Epub 2016 Oct 28.

17.

Ultra-Specific Isolation of Circulating Tumor Cells Enables Rare-Cell RNA Profiling.

Jack RM, Grafton MM, Rodrigues D, Giraldez MD, Griffith C, Cieslak R, Zeinali M, Kumar Sinha C, Azizi E, Wicha M, Tewari M, Simeone DM, Nagrath S.

Adv Sci (Weinh). 2016 Apr 18;3(9):1600063. eCollection 2016 Sep.

18.

Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study.

Zhang Z, Shiratsuchi H, Palanisamy N, Nagrath S, Ramnath N.

J Thorac Oncol. 2017 Feb;12(2):397-402. doi: 10.1016/j.jtho.2016.07.027. Epub 2016 Aug 6.

19.

Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?

Murlidhar V, Rivera-Báez L, Nagrath S.

Small. 2016 Sep;12(33):4450-63. doi: 10.1002/smll.201601394. Epub 2016 Jul 20. Review.

20.

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection.

Murlidhar V, Ramnath N, Nagrath S, Reddy RM.

Cancers (Basel). 2016 Jun 28;8(7). pii: E61. doi: 10.3390/cancers8070061. Review.

21.

Opportunities and Challenges for Pancreatic Circulating Tumor Cells.

Nagrath S, Jack RM, Sahai V, Simeone DM.

Gastroenterology. 2016 Sep;151(3):412-26. doi: 10.1053/j.gastro.2016.05.052. Epub 2016 Jun 20. Review.

PMID:
27339829
22.

GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.

Waghray M, Yalamanchili M, Dziubinski M, Zeinali M, Erkkinen M, Yang H, Schradle KA, Urs S, Pasca Di Magliano M, Welling TH, Palmbos PL, Abel EV, Sahai V, Nagrath S, Wang L, Simeone DM.

Cancer Discov. 2016 Aug;6(8):886-99. doi: 10.1158/2159-8290.CD-15-0947. Epub 2016 May 16.

23.

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251. Erratum in: Oncotarget. 2017 Jun 6;8(23 ):38075.

24.

Tunable Thermal-Sensitive Polymer-Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells.

Yoon HJ, Shanker A, Wang Y, Kozminsky M, Jin Q, Palanisamy N, Burness ML, Azizi E, Simeone DM, Wicha MS, Kim J, Nagrath S.

Adv Mater. 2016 Jun;28(24):4891-7. doi: 10.1002/adma.201600658. Epub 2016 Apr 26.

25.

Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel.

Tam AL, Lim HJ, Wistuba II, Tamrazi A, Kuo MD, Ziv E, Wong S, Shih AJ, Webster RJ 3rd, Fischer GS, Nagrath S, Davis SE, White SB, Ahrar K.

J Vasc Interv Radiol. 2016 Jan;27(1):8-19. doi: 10.1016/j.jvir.2015.10.019. Epub 2015 Nov 25. No abstract available.

26.

Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.

Reddy RM, Murlidhar V, Zhao L, Grabauskiene S, Zhang Z, Ramnath N, Lin J, Chang AC, Carrott P, Lynch W, Orringer MB, Beer DG, Nagrath S.

J Thorac Cardiovasc Surg. 2016 Mar;151(3):852-858. doi: 10.1016/j.jtcvs.2015.09.126. Epub 2015 Oct 22.

27.

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions.

Zhang Z, Ramnath N, Nagrath S.

Front Oncol. 2015 Sep 30;5:209. doi: 10.3389/fonc.2015.00209. eCollection 2015. Review.

28.

Breast cancer stem cells: current advances and clinical implications.

Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, Azizi E, Wicha MS.

Methods Mol Biol. 2015;1293:1-49. doi: 10.1007/978-1-4939-2519-3_1. Review.

PMID:
26040679
29.

"Universal" vitrification of cells by ultra-fast cooling.

Heo YS, Nagrath S, Moore AL, Zeinali M, Irimia D, Stott SL, Toth TL, Toner M.

Technology (Singap World Sci). 2015 Mar;3(1):64-71.

30.

Cascaded spiral microfluidic device for deterministic and high purity continuous separation of circulating tumor cells.

Kim TH, Yoon HJ, Stella P, Nagrath S.

Biomicrofluidics. 2014 Dec 5;8(6):064117. doi: 10.1063/1.4903501. eCollection 2014 Nov.

31.

Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model.

Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, Waghray M, Luker G, Simeone DM, Wicha MS, Beer DG, Ramnath N, Nagrath S.

Oncotarget. 2014 Dec 15;5(23):12383-97.

32.

A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.

Murlidhar V, Zeinali M, Grabauskiene S, Ghannad-Rezaie M, Wicha MS, Simeone DM, Ramnath N, Reddy RM, Nagrath S.

Small. 2014 Dec 10;10(23):4895-904. doi: 10.1002/smll.201400719. Epub 2014 Jul 29.

33.

Microbial isolations from maxillofacial operation theatre and its correlation to fumigation in a teaching hospital in India.

Bali R, Sharma P, Nagrath S, Gupta P.

J Maxillofac Oral Surg. 2014 Jun;13(2):128-32. doi: 10.1007/s12663-012-0458-3. Epub 2012 Nov 20.

34.

Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.

Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S.

Lab Chip. 2014 Jun 7;14(11):1891-900. doi: 10.1039/c4lc00136b. Epub 2014 Apr 10.

35.

Emerging role of nanomaterials in circulating tumor cell isolation and analysis.

Yoon HJ, Kozminsky M, Nagrath S.

ACS Nano. 2014 Mar 25;8(3):1995-2017. doi: 10.1021/nn5004277. Epub 2014 Mar 6. Review.

36.

Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets.

Yoon HJ, Kim TH, Zhang Z, Azizi E, Pham TM, Paoletti C, Lin J, Ramnath N, Wicha MS, Hayes DF, Simeone DM, Nagrath S.

Nat Nanotechnol. 2013 Oct;8(10):735-41. doi: 10.1038/nnano.2013.194. Epub 2013 Sep 29.

37.

Microfluidics and cancer: are we there yet?

Zhang Z, Nagrath S.

Biomed Microdevices. 2013 Aug;15(4):595-609. doi: 10.1007/s10544-012-9734-8. Review.

38.

Pharyngeal and peritonsillar abscess due to Leclercia adecarboxylata in an immunocompetant patient.

Bali R, Sharma P, Gupta K, Nagrath S.

J Infect Dev Ctries. 2013 Jan 15;7(1):46-50. doi: 10.3855/jidc.2651.

39.

Prion diseases: risks, characteristics, and infection control considerations in dentistry.

Bali Z, Bali RK, Nagrath S.

J Investig Clin Dent. 2011 Nov;2(4):236-40. doi: 10.1111/j.2041-1626.2011.00080.x. Epub 2011 Aug 5. Review.

PMID:
25426894
40.

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7. doi: 10.1073/pnas.1012539107. Epub 2010 Oct 7.

41.

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.

Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S.

Sci Transl Med. 2010 Mar 31;2(25):25ra23. doi: 10.1126/scitranslmed.3000403.

42.

Differential inertial focusing of particles in curved low-aspect-ratio microchannels.

Russom A, Gupta AK, Nagrath S, Di Carlo D, Edd JF, Toner M.

New J Phys. 2009 Jul 1;11:75025.

43.

The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients.

Sequist LV, Nagrath S, Toner M, Haber DA, Lynch TJ.

J Thorac Oncol. 2009 Mar;4(3):281-3. doi: 10.1097/JTO.0b013e3181989565.

44.

Detection of mutations in EGFR in circulating lung-cancer cells.

Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA.

N Engl J Med. 2008 Jul 24;359(4):366-77. doi: 10.1056/NEJMoa0800668. Epub 2008 Jul 2.

45.

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.

46.

Tuberculosis spine--a diagnostic conundrum. Case report.

Nagrath SP, Hazra DK, Pant PC, Seth HC.

J Assoc Physicians India. 1974 May;22(5):405-7. No abstract available.

PMID:
4423679
47.

Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis.

Kishore B, Nagrath SP, Mathur KS, Hazra DK, Agarwal BD.

J Assoc Physicians India. 1973 Oct;21(10):875-81. No abstract available.

PMID:
4793277
48.

Tropical eosinophilia in Western Uttar Pradesh: a clinical study.

Kishore B, Nagrath SP, Mathur KS, Patney NL, Rastogi SP.

Indian J Chest Dis. 1971 Oct;13(4):133-9. No abstract available.

PMID:
5148084
49.

The electrocardiograms in tropical eosinophilia: an analysis of 50 cases.

Kishore B, Mathur KS, Nagrath SP, Hazra DK, Rastogi SP.

J Assoc Physicians India. 1971 Oct;19(10):731-6. No abstract available.

PMID:
5132259
50.

Pulmonary blastomycosis.

Nagrath SP, Atal PR, Kishore B, Arora RC.

J Indian Med Assoc. 1971 Aug 16;57(4):144-5. No abstract available.

PMID:
5161604

Supplemental Content

Loading ...
Support Center